There are two possible reasons why the male is a recognized risk factor for the recurrence of HCC: androgen receptor activation may promote HCC cell progression and invasion, while the endogenous metabolite estrogen inhibits tumor growth due to its anti-proliferative, pro-apoptotic, and anti-angiogenic activities (34–37). The gene discussed is AR; the disease is hepatocellular carcinoma.